Cinnamic Acid Derivatives in Tuberculosis, Malaria and Cardiovascular Diseases - A Review

被引:0
作者
De, Prithwiraj [1 ,2 ]
Bedos-Belval, Florence [1 ,2 ]
Vanucci-Bacque, Corinne [1 ,2 ]
Baltas, Michel [1 ,2 ]
机构
[1] Univ Toulouse, UPS, LSPCMIB, F-31062 Toulouse 9, France
[2] CNRS, LSPCMIB, F-31062 Toulouse 9, France
关键词
Antituberculosis; Antimalarial agents; Cardiovascular diseases; Cinnamic acid; Cinnamide; Cinnamoyl ester; Cinnamic hydrazide; DRUG-RESISTANT TUBERCULOSIS; FARNESYLTRANSFERASE INHIBITORS; MYCOBACTERIUM-TUBERCULOSIS; ANTIMYCOBACTERIAL ACTIVITY; ANTIBACTERIAL ACTIVITY; OXIDATIVE MODIFICATION; BIOLOGICAL EVALUATION; ANTIMALARIAL AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS;
D O I
暂无
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Cinnamic acid and its phenolic analogues are natural substances. Chemically, cinnamic acids or the 3-phenyl acrylic acids, offer three main reactive sites: substitution on the phenyl ring, addition on the alpha,beta-unsaturation and reactions of the carboxylic acid. Owing to these chemical aspects, cinnamic acid derivatives received much attention in medicinal research as traditional as well as valuable scaffolds in recent synthetic bioactive agents. In the last two decades, there has been huge attention towards various cinnamoyl derivatives and their biological efficacy. This review provides a comprehensive literature compilation concerning the synthesis of various cinnamoyl acids, esters, amides, hydrazides and related derivatives and their biological activity evaluations against diseases such as tuberculosis and malaria, which are frequent in developing countries and cardiovascular diseases, which cause a high mortality rate worldwide. We envisage that our effort in this review contributes a much needed and timely addition to the literature of medicinal research.
引用
收藏
页码:747 / 768
页数:22
相关论文
共 116 条
  • [1] ANTIMALARIAL COMPOUNDS FROM HOSLUNDIA-OPPOSITA
    ACHENBACH, H
    WAIBEL, R
    NKUNYA, MHH
    WEENEN, H
    [J]. PHYTOCHEMISTRY, 1992, 31 (11) : 3781 - 3784
  • [2] Ahn BZ, 1996, CURR PHARM DESIGN, V2, P247
  • [3] Nonpeptide mimic of bradykinin with long-acting properties
    Aramori, I
    Zenkoh, J
    Morikawa, N
    Asano, M
    Hatori, C
    Sawai, H
    Kayakiri, H
    Satoh, S
    Inoue, T
    Abe, Y
    Sawada, Y
    Mizutani, T
    Inamura, N
    Iwami, M
    Nakahara, K
    Kojo, H
    Oku, T
    Notsu, Y
    [J]. IMMUNOPHARMACOLOGY, 1999, 45 (1-3): : 185 - 190
  • [4] Bainsborough H., 1928, LANCET, VI, P908
  • [5] Novel molecular hybrids of cinnamic acids and guanylhydrazones as potential antitubercular agents
    Bairwa, Ranjeet
    Kakwani, Manoj
    Tawari, Nilesh R.
    Lalchandani, Jaya
    Ray, M. K.
    Rajan, M. G. R.
    Degani, Mariam S.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1623 - 1625
  • [6] Baltas M., 2006, Int. Pat., Patent No. [WO/2006/ 037869, 2006037869]
  • [7] Characterization of an anti-tuberculosis resin glycoside from the prairie medicinal plant Ipomoea leptophylla
    Barnes, CC
    Smalley, MK
    Manfredi, KP
    Kindscher, K
    Loring, H
    Sheeley, DM
    [J]. JOURNAL OF NATURAL PRODUCTS, 2003, 66 (11): : 1457 - 1462
  • [8] Benveniste J., 1972, J EXP MEG, V136, P1356
  • [9] The role of oxidized lipoproteins in atherogenesis
    Berliner, JA
    Heinecke, JW
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (05) : 707 - 727
  • [10] In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper
    Bezerra, D. P.
    Castro, F. O.
    Alves, A. P. N. N.
    Pessoa, C.
    Moraes, M. O.
    Silveira, E. R.
    Lima, M. A. S.
    Elmiro, F. J. M.
    Costa-Lotufo, L. V.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (06) : 801 - 807